Strategies for Improving the Outcome of Patients with Poor Prognosis Prostate Cancers

This publication has 13 references indexed in Scilit:

• Conformai external beam treatment of prostate cancer
  Urology, 1997
• Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin
  New England Journal of Medicine, 1997
• PROSTATE-SPECIFIC ANTIGEN AFTER ANATOMIC RADICAL RETROPUBIC PROSTATECTOMY
  Urologic Clinics of North America, 1997
• Chronic rectal bleeding after high-dose conformal treatment of prostate cancer warrants modification of existing morbidity scales
  International Journal of Radiation Oncology*Biology*Physics, 1997
• Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31.
  Journal of Clinical Oncology, 1997
• Optimization of conformal radiation treatment of prostate cancer: Report of a dose escalation study
  International Journal of Radiation Oncology*Biology*Physics, 1997
• Early observations of acute and chronic toxicity & psa response in patients with carcinoma of the prostate treated on a dose escalation study with 3D-CRT
  International Journal of Radiation Oncology*Biology*Physics, 1994
• 3D conformal radiotherapy for the treatment of prostate cancer: Low risk of chronic rectal morbidity observed in a large series of patients
  International Journal of Radiation Oncology*Biology*Physics, 1993
• Prostate-specific antigen as a prognostic factor for prostate cancer treated by external beam radiotherapy
  International Journal of Radiation Oncology*Biology*Physics, 1992
• Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706
  International Journal of Radiation Oncology*Biology*Physics, 1991